Guardian Pharmacy Services, Inc. (NYSE:GRDN) Given Consensus Rating of “Buy” by Analysts

Guardian Pharmacy Services, Inc. (NYSE:GRDN) has received a consensus rating of “Buy” from the seven brokerages that are currently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. The average 12-month price target among brokers that have issued a report on the stock in the last year is $38.00.

Several equities analysts recently commented on the stock. Truist Financial increased their target price on shares of Guardian Pharmacy Services from $34.00 to $38.00 and gave the company a “buy” rating in a report on Thursday, March 12th. Stephens boosted their price target on shares of Guardian Pharmacy Services from $35.00 to $36.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 14th. Zacks Research upgraded shares of Guardian Pharmacy Services from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, March 18th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Guardian Pharmacy Services in a research note on Monday, December 29th. Finally, Oppenheimer lifted their price objective on Guardian Pharmacy Services from $35.00 to $38.00 and gave the stock an “outperform” rating in a report on Thursday, March 12th.

Guardian Pharmacy Services Price Performance

Shares of GRDN opened at $34.19 on Monday. Guardian Pharmacy Services has a 1 year low of $19.17 and a 1 year high of $38.12. The stock has a 50 day simple moving average of $32.88 and a two-hundred day simple moving average of $29.97. The firm has a market cap of $2.17 billion, a P/E ratio of 44.41 and a beta of 0.85.

Guardian Pharmacy Services (NYSE:GRDN) last posted its quarterly earnings results on Wednesday, March 11th. The company reported $0.37 EPS for the quarter, topping the consensus estimate of $0.27 by $0.10. The firm had revenue of $397.62 million for the quarter, compared to the consensus estimate of $390.04 million. Guardian Pharmacy Services had a net margin of 3.40% and a return on equity of 31.64%. The firm’s revenue for the quarter was up 17.4% compared to the same quarter last year. On average, equities analysts anticipate that Guardian Pharmacy Services will post 0.87 earnings per share for the current year.

Insider Buying and Selling at Guardian Pharmacy Services

In other Guardian Pharmacy Services news, Director John Ackerman sold 1,103,364 shares of Guardian Pharmacy Services stock in a transaction that occurred on Friday, March 20th. The stock was sold at an average price of $29.68, for a total value of $32,747,843.52. Following the transaction, the director directly owned 345,123 shares of the company’s stock, valued at $10,243,250.64. The trade was a 76.17% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Kendall Forbes sold 346,672 shares of the business’s stock in a transaction that occurred on Friday, March 20th. The shares were sold at an average price of $29.68, for a total value of $10,289,224.96. Following the completion of the sale, the insider owned 453,256 shares of the company’s stock, valued at $13,452,638.08. The trade was a 43.34% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 9,726,405 shares of company stock worth $288,679,700 over the last quarter. Company insiders own 63.71% of the company’s stock.

Institutional Investors Weigh In On Guardian Pharmacy Services

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. State of Alaska Department of Revenue bought a new stake in Guardian Pharmacy Services in the 3rd quarter worth $30,000. Ameritas Investment Partners Inc. increased its position in shares of Guardian Pharmacy Services by 26.5% in the third quarter. Ameritas Investment Partners Inc. now owns 1,647 shares of the company’s stock valued at $43,000 after acquiring an additional 345 shares during the period. Raymond James Financial Inc. bought a new position in shares of Guardian Pharmacy Services during the second quarter valued at about $43,000. Police & Firemen s Retirement System of New Jersey raised its stake in shares of Guardian Pharmacy Services by 76.8% during the second quarter. Police & Firemen s Retirement System of New Jersey now owns 2,444 shares of the company’s stock valued at $52,000 after acquiring an additional 1,062 shares during the last quarter. Finally, State of Wyoming purchased a new stake in shares of Guardian Pharmacy Services during the second quarter worth about $58,000.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.